Organization
Acasti Pharma, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Acasti Pharma, Inc.
... last price of 34.50c. Price/Sales of 0.37 [1.2]. 17:00 EDT [11.3%, 82.8%] Acasti Pharma soars 13.8% on spectacular volume Its MCap is CAD37.9 million (US$29.4 ...
... LAVAL, Qu├ębec, April 02, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti" or the "Corporation") (NASDAQ:ACST)(TSX-V:ACST) announces that in accordance with the ...
... $12.3 million. -- Gain of $8.8 million realized from the deconsolidation of Acasti Pharma (non-control position). -- Net income of $6.0 million versus $11.2 million ...
... (non-control position). -- Gain of $8.8 million realized from the deconsolidation of Acasti Pharma revenues for Q3 2017 were $12.3 million. Business and the sale ...
... Acasti Pharma Inc. (NASDAQ:ACST)(TSX VENTURE:ACST), a biopharmaceutical innovator focused on the research, development and ...
... The Price to Book of 17.5 [4.7]. 17:00 EST [-1.9%, 24.3%, CAD1,395] Acasti Pharma continues significant downtrend; drops 3.2% Its MCap is CAD29.8 million (US$24 ...
... Acasti Pharma Inc. ("Acasti" or the "Corporation") (NASDAQ:ACST)(TSX VENTURE:ACST) announces that in accordance with ...
Subscribe now for full coverage on Acasti Pharma, Inc.
Start My Free Trial